Article Detail

Home > Article Detail
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

Article Contents

    Development of a method for the determination of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone in dust using liquld chromatography tandem mass spectrometry

    Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
    2015, v.28 no.1, pp.1-7
    https://doi.org/10.5806/AST.2015.28.1.1





    • Downloaded
    • Viewed

    Abstract

    4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco specific nitrosamine found only intobacco products. The ability to monitor biomarker concentrations is very important in understanding environmentaltobacco smoke (ETS). In this study, an efficient and sensitive method for the analysis of NNK in dust wasdeveloped and validated using liquid chromatography tandem mass spectrometry. Dust was collected with filterpaper soaked in methanol. The standard solution and dust sample were diluted with 100 mM ammonium acetateand extracted using dichloromethane. Our calibration curves ranged from 25 to 104 pg/mL. Excellent linearitywas obtained with correlation coefficient values between 0.9996 and 1.0000. The limit of detection (LOD) was5 pg/mL (S/N ≥ 3) and the retention time was 10 min. The limit of quantification (LOQ) was 25 pg/mL, andthe acceptance criteria was the rate of 98-103% (80-120% at levels up to 3×LOQ). The coefficient of variations(CV) was 2.8%. Accuracies determined from dust samples spiked with four different levels of NNK racurvesranged that from 25 to 104 pg/mL. Excellent linearity was obtained between 92.1% and 114%. The precisionof the method was acceptable (5% of CV). The recovery rates of the whole analytical procedure at low, medium,and high levels were 105.7-116.5% for NNK. The carry-over effects during LC-MS/MS analysis were notobserved for NNK. This manuscript summarizes the scientific evidence on the use of markers to measure ETS.

    keywords
    4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Environmental tobacco smoke (ETS) Tobacco-specific nitrosamines (TSNAs) LC-MS/MS Dust


    Reference

    1

    1. Lyon, In ‘International Agency for Research on Cancer’, Monogr Eval Carcinog Risks Hum, 83, p1-1438, France 2004.

    2

    2. W. O. Spitzer, V. Lawrence, R. Dales, G. Hill, M. C. Archer, P. Clark, L. Abenhaim, J. Hardy, J. Sampalis and S. P. Pinfold, Clin Invest Med., 13(1), 17-42 (1990).

    3

    3. R. A. Jenkins, M. R. Guerin and B. A. Tomkins, ‘The Chemistry of Environmental Tobacco Smoke: Composition and Measurement’. Lewis Publisher, Boca Raton, Florida, 2000.

    4

    4. D. Hoffmann, I. Hoffmann and K. El Bayoumy, Chem. Res. Toxico., 14, 767-790 (2001).

    5

    5. G. E. Matt, P. J. Quintana, H. Destaillats, L. A. Gundel, M. Sleiman, B. C. Singer, P. Jacob III, N. Benowitz, J. P. Winickoff, V. Rehan, P. Talbot, S. Schick, J. Samet, Y. Wang, B. Hang, M. MartinsGreen, J. F. Pankow and M. F. Hovell, Environ Health Perspect, 119, 1218-26 (2011).

    6

    6. Lyon, In ‘International Agency for Research on Cancer’, Monogr Eval Carcinog Risks Hum, 37, p1-291, France, 1985.

    7

    7. J. M. Yuan, W. P. Koh, S. E. Murphy, Y. H. Fan, R. W. Wang, S. G. Carmella, S. M. Han, K. Wickham, Y. T. Gao, M. C. Yu and S. S. Hecht, Cancer Res., 69, 2990-2995 (2009).

    8

    8. S. S. Hecht, Chem. Res. Toxicol., 11, 559-603 (1998).

    9

    9. A. Burton, Environ Health Perspect, 119, A70-4 (2011).

    10

    10. J. P. Winickoff, J. Friebely, S. E. Tanski, C. Sherroda, G. E. Matt, M. F. Hovell and R. C. McMillen, Pediatrics, 123, e74-9 (2009).

    11

    11. M. W. Seong, J. S. Moon, J. H. Hwang, H. J. Ryu, S. J. Kang, S. Y. Kong, T. H. Um, J. G. Park, J. S. Lee and D. H. Lee, Clinica Chimica Acta, 411(1-2), 72-76 (2010).

    12

    12. L. Gatzke-Kopp and T. Beauchaine, Child Psychiatry Hum Dev, 38, 255-69 (2007).

    13

    13. C.-J. Hsieh, S.-F., Jeng, Y.-N. Su, H.-F. Liao, W.-S. Hsieh, K.-Y. Wu and P.-C. Chen, Nicotine Tob Res., 12, 1108-1117 (2010).

    14

    14. J. Makin, P. A. Fried and B. Watkinson, Neurotoxicol Teratol., 13, 5-12 (1991).

    15

    15. D. P. Strachan and D. G. Cook, Thorax, 52, 905-14 (1997).

    16

    16. D. G. Cook and D. P. Strachan, Thorax, 52, 1081-94 (1997).

    17

    17. D. G. Cook, D. P. Strachan and I. M. Carey, Thorax, 53, 884-93 (1998).

    18

    18. S. H. Hwang, J. H. Hwang, J. S. Moon and D. H. Lee, Korean J Pediatr, 55(2), 35-41 (2012)

    19

    19. G. E. Matt, P. J. E. Quintana, M. F. Hovell, J. T. Bernert, S. Song, N. Novianti, T. Juarez, J. Floro, C. Gehrman, M. Garcia and S. Larson, Tob Control, 13, 29-37 (2004).

    20

    20. N. Ramirez, M. Z. Ozel, A. C. Lewis, R. M. Marce, F. Borrull, J. F. Hamilton, J. Chromatogr A., 1219, 180-187 (2012).

    21

    21. Food and Drug Administration, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/UCM070107, Accessed 17.04.09.

    22

    22. H. Hongwei, Z. Xiaotao, T. Youngfeng, T. Gangling, L. Yulan, H. Qingyuan, Tian Youngfeng, Tang Gangling, Liu Yulan and Hu Qingyuan, J. Pharm. Biomed. Anal, 63, 17-22 (2012).

    상단으로 이동

    Analytical Science and Technology